Claassen, Jurgen A.H.R.
Radboud University Medical Center
14 papers on CoChatORCID 0000-0002-1778-8151
Most cited papers
- Verified
New insights into the genetic etiology of Alzheimer’s disease and related dementias
Bellenguez, C., Küçükali, F., Jansen, I. E., Kleineidam, L., Moreno-Grau, S., Amin, N., Naj, A. C., Campos-Martin, R., Grenier-Boley, B., Andrade, V., et al. (2022) · Nature Genetics
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 2,498
- Verified
Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels
Ju, Y.-E. S., Ooms, S. J., Sutphen, C., Macauley, S. L., Zangrilli, M. A., Jerome, G., Fagan, A. M., Mignot, E., Zempel, J. M., Claassen, J. A. H. R., et al. (2017) · Brain
Sleep and Wakefulness ResearchAlzheimer's disease research and treatments
Cited by 604
- Verified
Cerebral Autoregulation: An Overview of Current Concepts and Methodology with Special Focus on the Elderly
van Beek, A. H., Claassen, J. A., Rikkert, M. G. O., & Jansen, R. W. (2008) · Journal of Cerebral Blood Flow & Metabolism
Traumatic Brain Injury and Neurovascular DisturbancesHeart Rate Variability and Autonomic Control
Cited by 485
- Verified
Effect of 1 Night of Total Sleep Deprivation on Cerebrospinal Fluid β-Amyloid 42 in Healthy Middle-Aged Men: A Randomized Clinical Trial
Ooms, S., Overeem, S., Besse, K., Rikkert, M. O., Verbeek, M., & Claassen, J. A. H. R. (2014) · JAMA Neurology
Sleep and Wakefulness ResearchAlzheimer's disease research and treatments
Cited by 438
- Verified
Transcranial Doppler estimation of cerebral blood flow and cerebrovascular conductance during modified rebreathing
Claassen, J. A. H. R., Zhang, R., Fu, Q., Witkowski, S., & Levine, B. D. (2007) · Journal of Applied Physiology
Traumatic Brain Injury and Neurovascular DisturbancesCardiovascular and exercise physiology
Cited by 172
- Verified
Association Between Blood Pressure Variability With Dementia and Cognitive Impairment: A Systematic Review and Meta-Analysis
de Heus, R. A. A., Tzourio, C., Lee, E. J. L., Opozda, M., Vincent, A. D., Anstey, K. J., Hofman, A., Kario, K., Lattanzi, S., Launer, L. J., et al. (2021) · Hypertension
Dementia and Cognitive Impairment ResearchBlood Pressure and Hypertension Studies
Cited by 138
- Verified
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Jansen, I. E., van der Lee, S. J., Gomez-Fonseca, D., de Rojas, I., Dalmasso, M. C., Grenier-Boley, B., Zettergren, A., Mishra, A., Ali, M., Andrade, V., et al. (2022) · Acta Neuropathologica
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 132
- Verified
Structural network efficiency predicts conversion to dementia
Tuladhar, A. M., van Uden, I. W. M., Rutten-Jacobs, L. C. A., Lawrence, A., van der Holst, H., van Norden, A., de Laat, K., van Dijk, E., Claassen, J. A. H. R., Kessels, R. P. C., et al. (2016) · Neurology
Advanced Neuroimaging Techniques and ApplicationsFunctional Brain Connectivity Studies
Cited by 109
- Verified
Altered cerebral hemodynamics in early Alzheimer disease: a pilot study using transcranial Doppler
Claassen, J. A. H. R., Diaz-Arrastia, R., Martin-Cook, K., Levine, B. D., & Zhang, R. (2009) · Journal of Alzheimer's Disease
Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments
Cited by 95
- Verified
Blood Pressure Variability and Progression of Clinical Alzheimer Disease
de Heus, R. A. A., Olde Rikkert, M. G. M., Tully, P. J., Lawlor, B. A., Claassen, J. A. H. R., & for the NILVAD Study Group (2019) · Hypertension
Dementia and Cognitive Impairment ResearchBlood Pressure and Hypertension Studies
Cited by 88
- Verified
Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study
Müller, M., Kuiperij, H. B., Versleijen, A. A. M., Chiasserini, D., Farotti, L., Baschieri, F., Parnetti, L., Struyfs, H., De Roeck, N., Luyckx, J., et al. (2016) · Journal of Alzheimer’s Disease
MicroRNA in disease regulationDementia and Cognitive Impairment Research
Cited by 41
- Verified
Cognitive Outcomes of Long-term Benzodiazepine and Related Drug (BDZR) Use in People Living With Mild to Moderate Alzheimer's Disease: Results From NILVAD
Dyer, A. H., Murphy, C., Lawlor, B., Kennelly, S. P., Lawlor, B., Segurado, R., Kennelly, S., Olde Rikkert, M. G. M., Howard, R., Pasquier, F., et al. (2020) · Journal of the American Medical Directors Association
Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient Outcomes
Cited by 39
- Verified
Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
De Kort, A. M., Kuiperij, H. B., Alcolea, D., Kersten, I., Versleijen, A. A. M., Greenberg, S. M., Stoops, E., Schreuder, F. H. B. M., Klijn, C. J. M., Lleó, A., et al. (2021) · Alzheimer's Research & Therapy
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 13
- Verified
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer’s Disease Patients and Controls after Correction for Ventricular Volumes
van Waalwijk van Doorn, L. J. C., Gispert, J. D., Kuiperij, H. B., Claassen, J. A. H. R., Arighi, A., Baldeiras, I., Blennow, K., Bozzali, M., Castelo-Branco, M., Cavedo, E., et al. (2017) · Journal of Alzheimer’s Disease
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 13
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free